Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018

Olivier Bylicki, Pascale Tomasini, Radj Gervais, Florian Guisier, Isabelle Monnet, Charles Ricordel, L. Bigay-Gamé, Margaux Geier, C. Chouaïd, Catherine Daniel, Aurélie Swalduz, Anne‐Claire Toffart, H. Doubre, J.-M. Peloni, Diane Moreau, Fabien Subtil, Jean‐Michel Grellard, Marie Castéra, Bénédicte Clarisse, Pedro-Henrique Martins-Lavinas, C. Decroisette, Laurent Greillier